Thematic Research and Development Areas

Oncology Genomics

The prevention, early diagnosis and treatment of cancer otherwise known as oncology is an important branch of medicine. Alteration in genomic DNA is frequently associated with the initiation and development of cancers. Advances in genomic technologies has made it possible to probe the DNA, the transcribed product (mRNA) and Protein. Our aim at the CGNPH is to use cutting edge technologies to interrogate the genome of various cancer cells to identify unique omics signatures that could identify individual risk to the development of cancer, provide a means of less invasive diagnostic alternative to tissue removal and identify specific target for precision oncology.


Pharmacogenomics studies variations in the genetic make-up of an individual and relates this to drug response. The benefits of minimizing the risk of toxicity and increasing effectiveness are the key drivers of personalized medicine. At CGNPH, we aim to understand germline genetic variations that are present within our community by adopting a candidate gene approach and thereby address the lack of pharmacogenomic data as regards the therapy of non-communicable diseases.

Mental Health

Mental health is concerned with the overall emotional, psychological and social wellbeing. This affects how we think, feel, act and determine how we handle stress, relate to others and make choices. At CGNPH, we are committed to providing information, data and resources that may improve and speed the understanding of disease etiology, refinement of diagnostic systems and development of novel therapeutic agents and personalized care that will enhance provision of quality healthcare.

Genomics of Diabetes and Metabolic Syndrome

Metabolic syndrome is a multifactorial disease condition defined by a clustering of risk factors including hypertension, insulin resistance, and obesity. This clustering of risk factors predisposes an individual to an increased risk for diabetes and cardiovascular disease. Genomic studies are beginning to show a number of overlapping genes and polymorphisms that influence both the development of diabetes and Metabolic syndrome. At CGNPH, we are committed to providing genomic research data that will help revolutionize the screening, diagnosis and management of metabolic syndrome and diabetes with a view to ensuring personalized (tailored) health care to individual’s need.

Point-of-Care-Testing and Medical Devices

Point-of-care testing (POCT) is essential for the rapid detection of analytes near to the patient, which facilitates better disease diagnosis, monitoring, and management. At CGNPH, our R&D applies artificial intelligence, Big Data, and Machine learning techniques to provide better and personalized healthcare. We focus on developing from innovation through to commercialization, effective and affordable in-vitro POCT devices targeted at NCDs for low-income economies especially in Africa. We co-innovate with industrial partners to deliver better healthcare products and services.

Respiratory Diseases

Communicable and NCDs Interphase

Other NCDs

Career Opportunities

Applications are invited for Masters and Doctoral candidates across Africa who are interested in further studies in Genomics of NCDs at the Center for Genomics of NCDs and Personalized Healthcare. Please send a copy of your CV at for further information.

Press Coverage

Molecular Biology and Bioinformatics Workshop 2021
(Date to be announced soon)

Contact Us

+2348143875610, +2348091970600,

©2020 Ncdsgenomics. All Rights Reserved.